Inventor
Ping Huang
Inventor
Mountain View, CA, US
Overview
Patents· 20 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes14%
C07CAcyclic or carbocyclic compounds8%
C07HSugars4%
A23DEdible oils or fats, e.g. margarines, shortenings or cooking oils2%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for2%
B01DSeparation2%
C11BProducing, e.g. by pressing raw materials or by extraction from waste materials, refining or preserving fats, fatty substances, e.g. lanolin, fatty oils or waxes2%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture2%
PatentTitleYear
10,562,889Process for the preparation of 1-(arylmethyl)quinazoline-2,4(1H,3H)-diones202010,463,743Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof20199,533,054'Amphiphilic drug-drug conjugates for cancer therapy, compositions and methods of preparation and uses thereof'20179,113,650'Pectic enzyme treated pectin, method of producing the same and application thereof'20158,324,231'Pyrimidinones as casein kinase II (CK2) modulators'20128,242,129'6-phenylpyrimidinones as PIM modulators'20128,163,771'11 β-HSD1 modulators'20128,076,338'Kinase modulators and methods of use'20117,279,573'Amide derivatives'20077,186,832'Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors'20077,186,716'3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors'20077,157,460'Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors'20077,122,548'Triazolotriazine compounds and uses thereof'20067,064,121'N-acylated lipophilic amino acid derivatives'20067,053,086'4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors'20067,022,677'Amide derivatives as growth hormone secretagogues'20066,864,250'N-acylated lipophilic amino acid derivatives'20056,635,640'4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors'20036,596,772'Phosphate mimics and methods of treatment using phosphatase inhibitors'20036,465,507'3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors'2002Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2002–2007Patents assigned to SUGEN INC (8)· patent assignee history
2002–2012Based in Mountain View, CA, US· patent location history
2005–2007Patents assigned to MOLECULAR RES INST (4)· patent assignee history
2011–2012Patents assigned to EXELIXIS INC (4)· patent assignee history
2011–2012Patents assigned to HUANG PING (4)· patent assignee history
2011–2012Patents assigned to KIM MOON HWAN (3)· patent assignee history
2015Based in Taichung, TW· patent location history
2017–2020Based in Shanghai, CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SUGEN INC | 8 | 2002–2007 |
| EXELIXIS INC | 4 | 2011–2012 |
| HUANG PINGself | 4 | 2011–2012 |
| MOLECULAR RES INST | 4 | 2005–2007 |
| KIM MOON HWAN | 3 | 2011–2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Mountain View, California, US | 16 | 2002–2012 |
| Shanghai, CN | 3 | 2017–2020 |
| Taichung, TW | 1 | 2015 |